Gilead Sciences, Inc. (GIS.DE) XETRA

110.06

-0.24(-0.22%)

Updated at June 03 09:04AM

Currency In EUR

Valuation

Market Cap155.3B
Enterprise Value173.78B
P/E Ratio17.19
PEG Ratio0.31
Price/Sales Ratio5.33
Price/Book Ratio6.74
Enterprise/Revenue5.82
Enterprise/EBITDA12.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.31
Operating Margin0.38

Management Effectiveness

Return On Assets0.16
Return On Equity0.42

Income Statement

Revenue29.45B
Revenue/Share23.94
Gross Profit25.52B
EBITDA11.82B
Net Income8.51B
Diluted EPS6.78

Balance Sheet

Total Cash9.78B
Total Cash/Share7.9
Total Debt22.09B
Total Debt/Equity0.94
Current Ratio1.97
Book Value Per Share18.87

Price History

52-Week Change16.91
52-Week High132
52-Week Low89.96
Moving Average 50 Days115.6
Moving Average 200 Days110.62

Statistics

Average Volume835
Shares Outstanding1.24B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.19
Trailing Annual Dividend Yield2.5
Payout Ratio0.44
Last Split Factor2:1
Last Split DateJanuary 28, 2013